In this article
Why pre-market evidence is not the endSources of safety signalsInterpreting the data responsiblyWhat ordinary readers can doExample: putting the information in contextWhat to check nextFrequently asked questionsDoes TGA monitoring stop after a device is listed?Can DAEN counts be used to rank the safest brand?Read more on this topicOfficial sourcesRelated articles
Medical-device regulation continues after a product reaches the market. Post-market monitoring uses safety reports, complaints, literature, quality data and regulatory actions to identify emerging issues.
Why pre-market evidence is not the end
No pre-market programme can anticipate every real-world circumstance. Device populations, components and use environments vary, and new information can reveal issues that warrant investigation or action.
Sources of safety signals
Information can come from patient reports, health professionals, manufacturers, suppliers and TGA surveillance. The DAEN contains suspected adverse-event notifications; DRAC records market actions such as recalls and product corrections. These databases serve different purposes.
Interpreting the data responsibly
An adverse-event count is not a reliable comparison of product safety across brands because exposure, reporting rates and severity information vary. A report is not proof of causation. Conversely, an absence of public reports cannot establish that a device has no hazards.
What ordinary readers can do
Keep useful product identifiers, follow official notices and report serious suspected problems through appropriate channels. Maintain the product according to its IFU and speak to the treating practitioner when the issue affects clinical use.
Example: putting the information in context
A small number of complaints lead a supplier to investigate a component. The outcome might be an instruction update, correction or further monitoring. The existence of a complaint alone does not establish that all products are dangerous.
What to check next
- Use DAEN to understand suspected-event reporting limitations.
- Use DRAC to find regulatory market actions rather than allegations.
- Keep identification details and follow safety notices.
Frequently asked questions
Does TGA monitoring stop after a device is listed?
No. Ongoing vigilance and market action remain part of the framework.
Can DAEN counts be used to rank the safest brand?
No. The TGA warns against drawing safety conclusions from those reports alone.
Read more on this topic
- Medical Devices & TGA: topic overview
- Regulatory Terms: Approved, Included and Authorised
- What Is a Medicinal Cannabis Vaporising Device?
Official sources
- TGA — Medical device adverse events: DAEN and interpretation
- TGA — Database of Recalls, Product Alerts and Product Corrections
- TGA — Find information about a medical device: report a problem
This educational information is not individual medical advice. It does not establish the regulatory status or suitability of an unidentified device, and must not be read as authorisation to advertise vaping goods to the Australian public.